Literature DB >> 32029384

Annular versus supra-annular sizing for transcatheter aortic valve replacement in bicuspid aortic valve disease.

Jonathan R Weir-McCall1, Adrian Attinger-Toller2, Philipp Blanke3, Gidon Y Perlman4, Stephanie L Sellers3, David Wood5, John G Webb5, Jonathon Leipsic3.   

Abstract

BACKGROUND: CT measurement of supra-annular area (SA) has been proposed as an alternative to annular area (AA) for sizing of trancatheter valves in biscuspid aortic valves (BAV). This study examines the reproducibility of SA and AA measurements and their potential impact on downstream transcatheter heart valve sizing and clinical outcomes.
METHODS: 44 consecutive patients (mean age: 73 ± 15 years, 57% male) undergoing CTA with subsequent SAPIEN 3 valve insertion for severe bicuspid aortic stenosis (AS) were included. AA was measured at the basal ring. SA was measured by generating a circle defined by the intercommisural distance. AA and SA were measured by 2 independent observers. Baseline characteristics, TAVR procedural data, and discharge echocardiography data were collected.
RESULTS: The SA was significantly larger than the AA (562 ± 146mm2 vs. 518 ± 112mm2,p = 0.013). Interobserver agreement was high using both techniques (ICC AA = 0.98,p < 0.001; SA = 0.80,p < 0.001), but with narrower limits of agreement with AA measurements (mean difference (limits of agreement): AA = -3mm2 (22; 19), SA = -16mm2 (-92; 76)). AA-based device sizing demonstrated substantial agreement with final valve inserted (κ = 0.72,p < 0.001), while SA demonstrated fair agreement (κ = 0.40,p < 0.001). There was no difference in post TAVR gradients, paravalvular leakage or valve success between patients with concordant sizing between AA and SA, and those in whom SA would have suggested an alternate valve size.
CONCLUSIONS: Supra-annular sizing is less reproducible than annular sizing, with no difference in procedural complication rates in patients in whom supra-annular sizing would have altered the device size used. These results suggest no role for supra-annular sizing in current clinical practice.
Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Bicuspid aortic valve; Computer tomography; Tavr; Valvular disease

Mesh:

Year:  2020        PMID: 32029384     DOI: 10.1016/j.jcct.2020.01.008

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  9 in total

Review 1.  Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization.

Authors:  Tian-Yuan Xiong; Walid Ben Ali; Yuan Feng; Kentaro Hayashida; Hasan Jilaihawi; Azeem Latib; Michael Kang-Yin Lee; Martin B Leon; Raj R Makkar; Thomas Modine; Christoph Naber; Yong Peng; Nicolo Piazza; Michael J Reardon; Simon Redwood; Ashok Seth; Lars Sondergaard; Edgar Tay; Didier Tchetche; Wei-Hsian Yin; Mao Chen; Bernard Prendergast; Darren Mylotte
Journal:  Nat Rev Cardiol       Date:  2022-06-20       Impact factor: 32.419

2.  Long-Term Mortality After TAVI for Bicuspid vs. Tricuspid Aortic Stenosis: A Propensity-Matched Multicentre Cohort Study.

Authors:  Aleksandra Gasecka; Michał Walczewski; Adam Witkowski; Maciej Dabrowski; Zenon Huczek; Radosław Wilimski; Andrzej Ochała; Radosław Parma; Piotr Scisło; Bartosz Rymuza; Karol Zbroński; Piotr Szwed; Marek Grygier; Anna Olasińska-Wiśniewska; Dariusz Jagielak; Radosław Targoński; Grzegorz Opolski; Janusz Kochman
Journal:  Front Cardiovasc Med       Date:  2022-06-21

3.  Update on supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease according to the LIRA method.

Authors:  Gianmarco Iannopollo; Vittorio Romano; Antonio Esposito; Giulia Guazzoni; Marco Ancona; Luca Ferri; Filippo Russo; Barbara Bellini; Nicola Buzzatti; Jonathan Curio; Bernard Prendergast; Matteo Montorfano
Journal:  Eur Heart J Suppl       Date:  2022-05-18       Impact factor: 1.624

Review 4.  The Journal of Cardiovascular Computed Tomography: 2020 Year in review.

Authors:  Todd C Villines; Subhi J Al'Aref; Daniele Andreini; Marcus Y Chen; Andrew D Choi; Carlo N De Cecco; Damini Dey; James P Earls; Maros Ferencik; Heidi Gransar; Harvey Hecht; Jonathon A Leipsic; Michael T Lu; Mohamed Marwan; Pál Maurovich-Horvat; Edward Nicol; Gianluca Pontone; Jonathan Weir-McCall; Seamus P Whelton; Michelle C Williams; Armin Arbab-Zadeh; Gudrun M Feuchtner
Journal:  J Cardiovasc Comput Tomogr       Date:  2021-02-22

Review 5.  Bicuspid Valve Sizing for Transcatheter Aortic Valve Implantation: The Missing Link.

Authors:  Giulia Costa; Marco Angelillis; Anna Sonia Petronio
Journal:  Front Cardiovasc Med       Date:  2022-01-27

6.  The Presence of Calcified Raphe Is an Independent Predictor of Adverse Long-Term Clinical Outcomes in Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Yung-Tsai Lee; Wei-Hsian Yin; Tien-Ping Tsao; Kuo-Chen Lee; Ming-Chon Hsiung; Yun-Hsuan Tzeng; Jeng Wei
Journal:  Front Cardiovasc Med       Date:  2022-04-13

7.  Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis - 2 Years Follow up Experience From India.

Authors:  Vijay Kumar; G Sengottuvelu; Vivudh P Singh; Vishal Rastogi; Ashok Seth
Journal:  Front Cardiovasc Med       Date:  2022-07-28

8.  Procedural and clinical outcomes of transcatheter aortic valve replacement in bicuspid aortic valve patients: a systematic review and meta-analysis.

Authors:  Cheng-Hao Jacky Chen; Henry Jiang; Owen Martin; Ashley R Wilson-Smith
Journal:  Ann Cardiothorac Surg       Date:  2022-07

9.  Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis-A Multicenter Real-World Experience.

Authors:  Ahmed Elkoumy; John Jose; Christian J Terkelsen; Henrik Nissen; Sengottuvelu Gunasekaran; Mahmoud Abdelshafy; Ashok Seth; Hesham Elzomor; Sreenivas Kumar; Francesco Bedogni; Alfonso Ielasi; Santosh K Dora; Sharad Chandra; Keyur Parikh; Daniel Unic; William Wijns; Andreas Baumbach; Darren Mylotte; Patrick Serruys; Osama Soliman
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.